Demographics of Lung Cancer in Females
1 other identifier
observational
300
1 country
1
Brief Summary
Lung cancer has been the most common and fatal type of cancer; indeed worldwide incidence of lung cancer is alarming. It is considered a leading cause of cancer- related deaths among males and females due to environmental pollution, occupational exposure, genetic susceptibility, increasing number of smokers and others.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Aug 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 7, 2025
CompletedStudy Start
First participant enrolled
August 7, 2025
CompletedFirst Posted
Study publicly available on registry
August 14, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 7, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
April 7, 2027
August 18, 2026
August 1, 2026
1.3 years
August 7, 2025
August 16, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Risk factors of lung cancer in females
A retrospective cohort study will be conducted on bronchogenic carcinoma patients who had been presented to and diagnosed at chest diseases department, Oncology Center Mansoura University (OCMU) in last 10 years.
6 months
Study Arms (1)
bronchogenic carcinoma in female patients
A retrospective cohort study will be conducted on bronchogenic carcinoma female patients who had been presented to and diagnosed at chest diseases department, Oncology Center Mansoura University (OCMU).
Interventions
A retrospective cohort study will be conducted on bronchogenic carcinoma patients who had been presented to and diagnosed at chest diseases department, Oncology Center Mansoura University (OCMU).
Eligibility Criteria
A retrospective cohort study will be conducted on bronchogenic carcinoma patients who had been presented to and diagnosed at chest diseases department, Oncology Center Mansoura University (OCMU) in last 10 years.
You may qualify if:
- All female patients presented with bronchogenic carcinoma patients and diagnosed at chest diseases department, Oncology Center Mansoura University (OCMU) in last 10 years.
You may not qualify if:
- lung metastasis ( not primary bronchogenic carcinoma)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Mohamed AbdElmoniem
Al Mansurah, 35516, Egypt
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Mohamed AbdElmoniem
Lecturer of chest medicine faculty of medicine Mansoura university
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Lecturer of chest medicine faculty of medicine
Study Record Dates
First Submitted
August 7, 2025
First Posted
August 14, 2025
Study Start
August 7, 2025
Primary Completion (Estimated)
December 7, 2026
Study Completion (Estimated)
April 7, 2027
Last Updated
August 18, 2026
Record last verified: 2026-08
Data Sharing
- IPD Sharing
- Will not share